Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
Q4 2024 vs. Q3 2024
How the institutions holding Talis Biomedical Corp changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 2 | 1 | −1 |
| Shares | 248.8K | 14 | −248.8K (−100.0%) |
| Value | $460.4K | $26 | −$460.3K (−100.0%) |
New holders (1)
Institutions that held Talis Biomedical Corp at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Synergy Financial Management, LLC | 14 | $26 | 0.00% |
Sold out (2)
Institutions that held Talis Biomedical Corp at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| BML Capital Management, LLC | 248,702 | $460.1K |
| Steward Partners Investment Advisory, LLC | 147 | $272 |